IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 333 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,411,547 | +94.1% | 604,311 | +75.6% | 0.07% | +94.4% |
| Q2 2023 | $14,122,977 | +14.3% | 344,211 | -0.5% | 0.04% | +12.5% |
| Q1 2023 | $12,359,285 | -48.5% | 345,811 | -45.5% | 0.03% | -52.2% |
| Q4 2022 | $23,980,588 | -17.5% | 634,911 | -3.4% | 0.07% | -20.2% |
| Q3 2022 | $29,082,000 | +11.3% | 657,511 | -6.8% | 0.08% | +13.5% |
| Q2 2022 | $26,129,000 | +15.3% | 705,811 | +15.4% | 0.07% | +23.3% |
| Q1 2022 | $22,654,000 | +49.7% | 611,611 | +23.0% | 0.06% | +57.9% |
| Q4 2021 | $15,136,000 | +4.4% | 497,411 | +15.1% | 0.04% | 0.0% |
| Q3 2021 | $14,496,000 | -30.9% | 432,211 | -17.8% | 0.04% | -30.9% |
| Q2 2021 | $20,975,000 | -34.7% | 525,811 | -26.4% | 0.06% | -37.5% |
| Q1 2021 | $32,120,000 | -29.0% | 714,411 | -10.7% | 0.09% | -27.3% |
| Q4 2020 | $45,244,000 | -12.5% | 800,211 | -26.6% | 0.12% | -18.2% |
| Q3 2020 | $51,726,000 | -25.1% | 1,090,111 | -7.0% | 0.15% | -27.1% |
| Q2 2020 | $69,084,000 | +23.1% | 1,171,711 | -1.3% | 0.20% | -5.6% |
| Q1 2020 | $56,131,000 | -32.0% | 1,187,211 | -13.1% | 0.22% | +12.0% |
| Q4 2019 | $82,569,000 | -14.6% | 1,366,811 | -15.3% | 0.19% | -19.0% |
| Q3 2019 | $96,719,000 | -7.9% | 1,614,411 | -1.2% | 0.24% | -9.2% |
| Q2 2019 | $105,063,000 | +60.4% | 1,634,711 | +102.6% | 0.26% | +58.2% |
| Q1 2019 | $65,497,000 | +99.6% | 806,911 | +33.0% | 0.16% | +83.3% |
| Q4 2018 | $32,810,000 | +106.4% | 606,911 | +96.9% | 0.09% | +130.8% |
| Q3 2018 | $15,898,000 | +702.9% | 308,211 | +548.7% | 0.04% | +680.0% |
| Q2 2018 | $1,980,000 | -72.5% | 47,511 | -70.9% | 0.01% | -75.0% |
| Q1 2018 | $7,208,000 | -1.8% | 163,511 | +12.1% | 0.02% | 0.0% |
| Q4 2017 | $7,339,000 | +303.0% | 145,911 | +306.3% | 0.02% | +300.0% |
| Q3 2017 | $1,821,000 | +23.0% | 35,911 | +23.4% | 0.01% | 0.0% |
| Q2 2017 | $1,481,000 | +417.8% | 29,111 | +309.4% | 0.01% | +400.0% |
| Q1 2017 | $286,000 | -75.9% | 7,111 | -71.3% | 0.00% | -80.0% |
| Q4 2016 | $1,187,000 | -54.5% | 24,811 | -65.2% | 0.01% | -54.5% |
| Q3 2016 | $2,609,000 | -32.4% | 71,211 | -57.0% | 0.01% | -45.0% |
| Q2 2016 | $3,859,000 | -65.5% | 165,711 | -40.0% | 0.02% | -68.3% |
| Q1 2016 | $11,195,000 | -54.3% | 276,411 | -30.1% | 0.06% | -56.8% |
| Q4 2015 | $24,496,000 | – | 395,539 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |